The DETECT T1D Live Summit series brings together multidisciplinary faculty and a type 1 diabetes (T1D) patient advocate to discuss practical considerations in screening, follow-up, early referral, and treatment to delay T1D progression.
Hear expert guidance on how to inform decisions about advancing therapy and to recognize all patients who would benefit from approved biologic therapies targeting IL-13 based on the pathophysiology of Atopic Dermatitis.
Join us for a complimentary dinner and CME as our experts discuss the latest efficacy and safety data from clinical trials of newly approved and emerging therapies and new therapeutic combinations for small cell lung cancer (SCLC).
